MY189837A - Use of eurycoma longifolia extract as antiviral - Google Patents

Use of eurycoma longifolia extract as antiviral

Info

Publication number
MY189837A
MY189837A MYPI2016702017A MYPI2016702017A MY189837A MY 189837 A MY189837 A MY 189837A MY PI2016702017 A MYPI2016702017 A MY PI2016702017A MY PI2016702017 A MYPI2016702017 A MY PI2016702017A MY 189837 A MY189837 A MY 189837A
Authority
MY
Malaysia
Prior art keywords
dengue
eurycoma longifolia
antiviral
treatment
provides
Prior art date
Application number
MYPI2016702017A
Inventor
M Chinnappan Sasikala
Haslina Md Akir Mazria
George Annie
Original Assignee
Biotropics Malaysia Berhad
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotropics Malaysia Berhad filed Critical Biotropics Malaysia Berhad
Priority to MYPI2016702017A priority Critical patent/MY189837A/en
Priority to PH12017000166A priority patent/PH12017000166A1/en
Priority to BR102017011783A priority patent/BR102017011783A2/en
Publication of MY189837A publication Critical patent/MY189837A/en

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention provides a safe and effective preventive or treatment of antiviral disease, in particular for the prevention or treatment of dengue fever. Simultaneously, the present invention provides a new kind of medicinal value or health care function Eurycoma longifolia or traditionally known as Tongkat Ali. Accordingly, the present invention provides surprising effects of Eurycoma longifolia extract as an antiviral against dengue, in particular reducing the count of dengue virus replication, thereby effective in the treatment, amelioration, management or prevention of dengue disease caused by dengue virus. Also provided are surprising effects of Eurycoma longifolia extract in increasing platelet count, thereby effective in the treatment, amelioration, management or prevention of dengue disease caused by dengue virus. Further, the present invention provides an antiviral drug or pharmaceutical composition comprising Eurycoma longifolia extract as an alternative product to fight dengue disease. Figure 1
MYPI2016702017A 2016-06-02 2016-06-02 Use of eurycoma longifolia extract as antiviral MY189837A (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
MYPI2016702017A MY189837A (en) 2016-06-02 2016-06-02 Use of eurycoma longifolia extract as antiviral
PH12017000166A PH12017000166A1 (en) 2016-06-02 2017-06-02 Use of eurycoma longifolia extract as antiviral
BR102017011783A BR102017011783A2 (en) 2016-06-02 2017-06-02 use of eurycoma longifolia extract as antiviral

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MYPI2016702017A MY189837A (en) 2016-06-02 2016-06-02 Use of eurycoma longifolia extract as antiviral

Publications (1)

Publication Number Publication Date
MY189837A true MY189837A (en) 2022-03-11

Family

ID=62617521

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2016702017A MY189837A (en) 2016-06-02 2016-06-02 Use of eurycoma longifolia extract as antiviral

Country Status (3)

Country Link
BR (1) BR102017011783A2 (en)
MY (1) MY189837A (en)
PH (1) PH12017000166A1 (en)

Also Published As

Publication number Publication date
BR102017011783A2 (en) 2018-02-06
PH12017000166A1 (en) 2018-07-16

Similar Documents

Publication Publication Date Title
MY180145A (en) Cenicriviroc compositions and methods of making and using the same
IN2014DN06501A (en)
CL2015000039A1 (en) Estra-1,3,5 (10), 16-tetraeno-3-substituted derivatives, pharmaceutical preparations that comprise them and their use in the preparation of medicaments for treating endometriosis.
MX2017004772A (en) Compositions and methods for physiological delivery using cannabidiol.
BR102013003570A8 (en) PLATELET-RICH PLASMA COMPOSITIONS
WO2018025080A3 (en) Compositions for enhancing brain activity
PH12016502233A1 (en) (s)-pirlindole or its pharmaceutically acceptable salts for use in medicine
MY194024A (en) Use of cistanche tubulosa extract and isoacteoside in protection of muscles
UY35890A (en) USE OF LAQUINIMOD TO DELAY THE PROGRESSION OF HUNTINGTON'S DISEASE
WO2011055931A3 (en) Composition for preventing or treating diseases caused by influenza viruses
CO6241128A2 (en) EXTRACTED COMPOUNDS OF PALM OIL GRINDING WASTE FOR CANCER TREATMENT COMPOSITIONS OF THE SAME AND ACCOMPANYING METHODS
MY189837A (en) Use of eurycoma longifolia extract as antiviral
ITUA20164387A1 (en) Pharmaceutical composition comprising Cetraria islandica Ach., Sodium hyaluronate and a saline solution for the treatment of diseases of the respiratory system.
EP3417869A4 (en) Composition containing phragmitis rhizoma extract as active ingredient for preventing, ameliorating, or treating disease attributed to side effect of anticancer agent
WO2016159584A3 (en) Composition for innate immunity enhancement and antiviral activity containing extract of mori ramulus or mori radicis cortex as active ingredient
WO2016159583A3 (en) Composition for innate immunity enhancement and antiviral activity containing hovenia dulcis extract as active ingredient
MX2017013643A (en) Tamper-resistant fixed dose combination providing fast release of two drugs from particles and a matrix.
BR112015020566A2 (en) ror gamma modulators
PH12020500120A1 (en) Pharmaceutical compositions
SG11201806628UA (en) New bi-aromatic propynyl compounds, pharmaceutical and cosmetic compositions containing them and uses thereof
PH12017501949A1 (en) Amyloid � fibril decomposing agent, and therapeutic or preventive agent and therapeutic or preventive food composition for diseases caused by amyloid � fibril formation
ZA202104321B (en) Aqueous paediatric retinol formulations
UY35784A (en) PHARMACEUTICAL DOSAGE FORMS INCLUDING 1- [6- (MORFOLIN-4-IL) PYRIMIDIN-4-IL] -4- (1H- 1,2,3-TRIAZOL-1-IL) -1H-PIRAZOL-5-OLATE OF SODIUM
HRP20231197T1 (en) Use of tamoxifen for the treatment of cystic fibrosis in non-female patients
RODRIGUEZ Synergistic Effect of Lupenone and Caryophyllene Oxide against Trypanosoma cruzi